83 related articles for article (PubMed ID: 3712417)
1. Anti-brush border antibodies (ABBA) in sera from patients with ulcerative proctocolitis and in sera with antibodies against Yersinia enterocolitica 0:3.
Skogh T; Bodemar G; Kihlström E; Ljunghusen O
J Clin Lab Immunol; 1986 Mar; 19(3):117-8. PubMed ID: 3712417
[TBL] [Abstract][Full Text] [Related]
2. [Significance of serum antibodies ANCA, ASCA, ABBA in diagnostics of idiopathic intestinal inflammations].
Pintér M; Pintérová KM; Drahosová M; Rejchrt S; Douda T; Tachecí I; Kopácová M; Bures J
Cas Lek Cesk; 2007; 146(11):863-7. PubMed ID: 18069213
[TBL] [Abstract][Full Text] [Related]
3. Anti-brush border antibodies (ABBA) in Crohn's disease.
Skogh T; Heuman R; Tagesson C
J Clin Lab Immunol; 1982 Dec; 9(3):147-50. PubMed ID: 6762441
[TBL] [Abstract][Full Text] [Related]
4. [Humoral response to selected antigens of Yersinia enterocolitica and Yersinia pseudotuberculosis in the course of yersiniosis in humans. I. Occurrence of antibodies to Yersinia lipopolisacharydes and Yop proteins by ELISA].
Rastawicki W
Med Dosw Mikrobiol; 2006; 58(4):303-19. PubMed ID: 17642308
[TBL] [Abstract][Full Text] [Related]
5. Serological studies in Crohn's disease.
Ibbotson JP; Pease PE; Allan RN
Eur J Clin Microbiol; 1987 Jun; 6(3):286-90. PubMed ID: 3305007
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum anti-carbonic anhydrase II antibodies in patients with ulcerative colitis.
Andoh A; Fujiyama Y; Yoshioka U; Sasaki M; Araki Y; Tsujikawa T; Bamba T
Int J Mol Med; 2002 May; 9(5):499-502. PubMed ID: 11956656
[TBL] [Abstract][Full Text] [Related]
7. Antibodies against Yersinia enterocolitica in patients with Reiter's syndrome.
Kobayashi S; Ogasawara M; Maeda K; Yu DT
J Lab Clin Med; 1985 Mar; 105(3):380-9. PubMed ID: 3871831
[TBL] [Abstract][Full Text] [Related]
8. Immunogenetic and microbial factors in acute anterior uveitis.
Careless DJ; Chiu B; Rabinovitch T; Wade J; Inman RD
J Rheumatol; 1997 Jan; 24(1):102-8. PubMed ID: 9002019
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to ubiquitin in relation to Yersinia infection status in patients with ankylosing spondylitis.
Hrycaj P; Łacki JK
Clin Rheumatol; 2003 Feb; 22(1):33-6. PubMed ID: 12605315
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies against human tropomyosin isoform 5 in ulcerative colitis destroys colonic epithelial cells through antibody and complement-mediated lysis.
Ebert EC; Geng X; Lin J; Das KM
Cell Immunol; 2006 Nov; 244(1):43-9. PubMed ID: 17416356
[TBL] [Abstract][Full Text] [Related]
11. Anti-endothelial cell antibodies in sera from patients with inflammatory bowel disease.
Aldebert D; Notteghem B; Reumaux D; Lassalle P; Lion G; Desreumaux P; Duthilleul P; Colombel JF
Gastroenterol Clin Biol; 1995 Nov; 19(11):867-70. PubMed ID: 8746043
[TBL] [Abstract][Full Text] [Related]
12. [Antibodies to Yersinia enterocolitica in immunogenic thyroid diseases].
Petru G; Stünzner D; Lind P; Eber O; Möse JR
Acta Med Austriaca; 1987; 14(1):11-4. PubMed ID: 3618088
[TBL] [Abstract][Full Text] [Related]
13. Alterations in serum anti-alpha-galactosyl antibodies in patients with Crohn's disease and ulcerative colitis.
D'Alessandro M; Mariani P; Lomanto D; Bachetoni A; Speranza V
Clin Immunol; 2002 Apr; 103(1):63-8. PubMed ID: 11987986
[TBL] [Abstract][Full Text] [Related]
14. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
[TBL] [Abstract][Full Text] [Related]
15. [Humoral response to selected antigens of Yersinia enterocolitica and Yersinia pseudotuberculosis in the course of yersiniosis in humans. I. Occurrence of antibodies to Yersinia Yop proteins by Western-blot].
Rastawicki W
Med Dosw Mikrobiol; 2006; 58(4):321-8. PubMed ID: 17642309
[TBL] [Abstract][Full Text] [Related]
16. [Significance of the determination of antineutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis and Crohn's disease].
García-Herola A; Nos P; Hoyos M; Hinojosa J; Molés JR; Pascual S; Bustamante M; Sánchez Cuenca JM; Carmona E; Ponce J; Berenguer J
Gastroenterol Hepatol; 1998 Apr; 21(4):169-73. PubMed ID: 9633176
[TBL] [Abstract][Full Text] [Related]
17. Relationship between thyroid autoimmunity and Yersinia enterocolitica antibodies.
Corapçioğlu D; Tonyukuk V; Kiyan M; Yilmaz AE; Emral R; Kamel N; Erdoğan G
Thyroid; 2002 Jul; 12(7):613-7. PubMed ID: 12193307
[TBL] [Abstract][Full Text] [Related]
18. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease.
Kossa K; Coulthart A; Ives CT; Pusey CD; Hodgson HJ
Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):783-9. PubMed ID: 7496870
[TBL] [Abstract][Full Text] [Related]
19. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].
Mokrowiecka A; Gasiorowska A; Małecka-Panas E
Pol Merkur Lekarski; 2004; 17 Suppl 1():22-6. PubMed ID: 15603341
[TBL] [Abstract][Full Text] [Related]
20. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS
Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
